BioNTech SE (NAS:BNTX)
$ 92.08 -3.92 (-4.08%) Market Cap: 22.19 Bil Enterprise Value: 5.42 Bil PE Ratio: 185.65 PB Ratio: 1.01 GF Score: 66/100

BioNTech SE at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 24, 2021 / 06:00PM GMT
Release Date Price: $114.17 (+1.96%)
Daina Michelle Graybosch
SVB Leerink LLC, Research Division - MD & Senior Research Analyst

Hello, everyone. Welcome to our post-lunch fireside chat with BioNTech. I'm really thrilled that Ugur Sahin is giving us a half an hour of this time, and we could take hours, I'm sure, with everything going on with COVID infectious disease and oncology at BioNTech.

Questions & Answers

Daina Michelle Graybosch
SVB Leerink LLC, Research Division - MD & Senior Research Analyst

So with that, I think I will jump right in. I will say, please do send me any questions. There's a place to enter it below this video, and I will try to fit them in as well in this half an hour.

So maybe starting broad, Ugur. The last year has been really transformational for mRNA vaccines. And I wonder how the year now has changed BioNTech in terms of your focus and journey and what will BioNTech be in 5 years from now?

Ugur Sahin
BioNTech SE - Co-Founder, CEO & Member of Management Board

This is a great question, Daina.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot